Follow
Anders Lilja
Anders Lilja
Valneva
Verified email at ebolaswede.com
Title
Cited by
Cited by
Year
A cationic nanoemulsion for the delivery of next-generation RNA vaccines
LA Brito, M Chan, CA Shaw, A Hekele, T Carsillo, M Schaefer, J Archer, ...
Molecular Therapy 22 (12), 2118-2129, 2014
3292014
Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes
C Ciferri, S Chandramouli, D Donnarumma, PA Nikitin, MA Cianfrocco, ...
Proceedings of the National Academy of Sciences 112 (6), 1767-1772, 2015
1792015
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody
S Chandramouli, C Ciferri, PA Nikitin, S Caló, R Gerrein, K Balabanis, ...
Nature communications 6 (1), 8176, 2015
1172015
Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice
Y Wen, J Monroe, C Linton, J Archer, CW Beard, SW Barnett, G Palladino, ...
Vaccine 32 (30), 3796-3804, 2014
1002014
Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types
AE Lilja, T Shenk
Proceedings of the National Academy of Sciences 105 (50), 19950-19955, 2008
892008
Recombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc
M Cortese, S Calò, R D'Aurizio, A Lilja, N Pacchiani, M Merola
PloS one 7 (11), e50166, 2012
632012
Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies
RJ Loomis, AE Lilja, J Monroe, KA Balabanis, LA Brito, G Palladino, ...
Vaccine 31 (6), 919-926, 2013
582013
The next generation recombinant human cytomegalovirus vaccine candidates—beyond gB
AE Lilja, PW Mason
Vaccine 30 (49), 6980-6990, 2012
582012
A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL
Y Xing, SL Oliver, TV Nguyen, C Ciferri, A Nandi, J Hickman, C Giovani, ...
Proceedings of the National Academy of Sciences 112 (19), 6056-6061, 2015
502015
Functional genetic analysis of rhesus cytomegalovirus: Rh01 is an epithelial cell tropism factor
AE Lilja, WLW Chang, PA Barry, SP Becerra, TE Shenk
Journal of virology 82 (5), 2170-2181, 2008
482008
Additive protection against congenital cytomegalovirus conferred by combined glycoprotein B/pp65 vaccination using a lymphocytic choriomeningitis virus vector
MR Schleiss, U Berka, E Watson, M Aistleithner, B Kiefmann, B Mangeat, ...
Clinical and vaccine immunology 24 (1), e00300-16, 2017
422017
Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO system
I Hofmann, Y Wen, C Ciferri, A Schulze, V Fühner, M Leong, A Gerber, ...
Biotechnology and bioengineering 112 (12), 2505-2515, 2015
422015
The Human Cytomegalovirus UL116 Gene Encodes an Envelope Glycoprotein Forming a Complex with gH Independently from gL
S Caló, M Cortese, C Ciferri, L Bruno, R Gerrein, B Benucci, G Monda, ...
Journal of Virology 90 (10), 4926-4938, 2016
382016
Geometric and dynamic requirements for DNA looping, wrapping and unwrapping in the activation of E. coli glnAp2 transcription by NtrC
AE Lilja, JR Jenssen, JD Kahn
Journal of molecular biology 342 (2), 467-478, 2004
382004
Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs
P Suphaphiphat, M Franti, A Hekele, A Lilja, T Spencer, E Settembre, ...
Virology journal 7, 1-5, 2010
322010
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody. Nat Commun 6: 8176
S Chandramouli, C Ciferri, PA Nikitin, S Calo, R Gerrein, K Balabanis, ...
272015
A randomized dose-escalating phase I trial of a replication-deficient lymphocytic choriomeningitis virus vector-based vaccine against human cytomegalovirus
M Schwendinger, G Thiry, B De Vos, G Leroux-Roels, J Bruhwyler, ...
The Journal of infectious diseases 225 (8), 1399-1410, 2022
232022
The susceptibility of primary cultured rhesus macaque kidney epithelial cells to rhesus cytomegalovirus strains
Y Yue, A Kaur, A Lilja, DJ Diamond, MR Walter, PA Barry
Journal of General Virology 97 (6), 1426-1438, 2016
212016
Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens
PP MacMaster, JL Shields, QA Alayo, C Cabral, J Jimenez, J Mondesir, ...
Vaccine 35 (1), 1-9, 2017
182017
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim …
C Taucher, R Lazarus, H Dellago, G Maurer, P Weisova, I Corbic-Ramljak, ...
Journal of Infection 87 (3), 242-254, 2023
82023
The system can't perform the operation now. Try again later.
Articles 1–20